- Home
- LICN vs VNRX Comparison
LICN vs VNRX Comparison
Compare LICN & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICN
- VNRX
- Stock Information
- Founded
- LICN 2004
- VNRX N/A
- Country
- LICN China
- VNRX United States
- Employees
- LICN N/A
- VNRX N/A
- Industry
- LICN
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LICN
- VNRX Health Care
- Exchange
- LICN Nasdaq
- VNRX Nasdaq
- Market Cap
- LICN 55.9M
- VNRX 65.0M
- IPO Year
- LICN 2023
- VNRX N/A
- Fundamental
- Price
- LICN $1.53
- VNRX $0.70
- Analyst Decision
- LICN
- VNRX Buy
- Analyst Count
- LICN 0
- VNRX 3
- Target Price
- LICN N/A
- VNRX $3.75
- AVG Volume (30 Days)
- LICN 384.4K
- VNRX 175.4K
- Earning Date
- LICN 11-06-2024
- VNRX 08-14-2024
- Dividend Yield
- LICN N/A
- VNRX N/A
- EPS Growth
- LICN N/A
- VNRX N/A
- EPS
- LICN 0.32
- VNRX N/A
- Revenue
- LICN $39,759,000.00
- VNRX $976,516.00
- Revenue This Year
- LICN N/A
- VNRX $207.88
- Revenue Next Year
- LICN N/A
- VNRX $473.19
- P/E Ratio
- LICN $4.78
- VNRX N/A
- Revenue Growth
- LICN 17.61
- VNRX 88.32
- 52 Week Low
- LICN $0.50
- VNRX $0.43
- 52 Week High
- LICN $2.44
- VNRX $1.38
- Technical
- Relative Strength Index (RSI)
- LICN 31.14
- VNRX 56.42
- Support Level
- LICN $1.89
- VNRX $0.63
- Resistance Level
- LICN $2.30
- VNRX $0.73
- Average True Range (ATR)
- LICN 0.20
- VNRX 0.06
- MACD
- LICN -0.06
- VNRX 0.01
- Stochastic Oscillator
- LICN 20.61
- VNRX 73.81
About LICN Lichen China Limited
Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.